[go: up one dir, main page]

ATE344659T1 - Tablettenzubereitung mit verlängerter freisetzung von venlafaxin - Google Patents

Tablettenzubereitung mit verlängerter freisetzung von venlafaxin

Info

Publication number
ATE344659T1
ATE344659T1 AT03101216T AT03101216T ATE344659T1 AT E344659 T1 ATE344659 T1 AT E344659T1 AT 03101216 T AT03101216 T AT 03101216T AT 03101216 T AT03101216 T AT 03101216T AT E344659 T1 ATE344659 T1 AT E344659T1
Authority
AT
Austria
Prior art keywords
core
venlafaxine
filler
cellulosic polymer
microcrystalline cellulose
Prior art date
Application number
AT03101216T
Other languages
English (en)
Inventor
Sima Volpert
Avi Avramoff
Original Assignee
Dexcel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE344659(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dexcel Ltd filed Critical Dexcel Ltd
Application granted granted Critical
Publication of ATE344659T1 publication Critical patent/ATE344659T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03101216T 2003-05-02 2003-05-02 Tablettenzubereitung mit verlängerter freisetzung von venlafaxin ATE344659T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03101216.4A EP1473030B2 (de) 2003-05-02 2003-05-02 Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin

Publications (1)

Publication Number Publication Date
ATE344659T1 true ATE344659T1 (de) 2006-11-15

Family

ID=32981939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03101216T ATE344659T1 (de) 2003-05-02 2003-05-02 Tablettenzubereitung mit verlängerter freisetzung von venlafaxin

Country Status (9)

Country Link
US (1) US8105627B2 (de)
EP (1) EP1473030B2 (de)
AT (1) ATE344659T1 (de)
CA (1) CA2524241A1 (de)
DE (1) DE60309565T3 (de)
ES (1) ES2277030T3 (de)
HK (1) HK1070821A1 (de)
PT (1) PT1473030E (de)
WO (1) WO2004096186A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1473030B2 (de) 2003-05-02 2014-05-14 Dexcel Ltd. Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
US20080175873A1 (en) * 2005-06-02 2008-07-24 Biovail Laboratories International S.R.L. Modified release composition of at least one form of venlafaxine
WO2006136927A1 (en) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Extended release formulations comprising venlafaxine
WO2007011619A2 (en) * 2005-07-15 2007-01-25 Wyeth Highly bioavailable oral delayed release dosage forms of o-desmethylvenlafaxine succinate
WO2007112574A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Extended release composition of venlafaxine
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
EP2074993A1 (de) * 2007-12-19 2009-07-01 Biovail Laboratories International S.r.l. Venlafaxin enthaltende Filmtabletten mit modifizierter Wirkstofffreisetzung
US20110052690A1 (en) * 2008-06-02 2011-03-03 Avi Avramoff Process for manufacture of a medicament with granulation and pan coating
WO2010089775A2 (en) * 2009-02-05 2010-08-12 Getz Pharma Research Improved drug dosage form for controlled delivery of one or more pharmaceutically active agent
WO2011141791A2 (en) * 2010-05-14 2011-11-17 Alembic Limited Extended release formulations of desvenlafaxine base
US9333175B2 (en) 2010-06-16 2016-05-10 Mylan Inc. Controlled release levetiracetam formulations and methods for producing the same
US20120251588A1 (en) * 2011-03-30 2012-10-04 Miyuki Fukasawa Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
US4657757A (en) † 1985-03-29 1987-04-14 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
GB9401894D0 (en) * 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
US6274171B1 (en) † 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE60034142T2 (de) * 1999-11-22 2007-12-13 Alza Corp., Mountain View Darreichungsform mit einer inneren Membran, einer Verdrängungszusammentzung und einer äußeren semipermeablen Membran
US6350471B1 (en) † 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1473030B2 (de) 2003-05-02 2014-05-14 Dexcel Ltd. Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
EP1523981A1 (de) † 2003-10-13 2005-04-20 Wyeth Venlafaxine-Zubereitungen mit verlängerter Freisetzung

Also Published As

Publication number Publication date
US20070082049A1 (en) 2007-04-12
EP1473030B2 (de) 2014-05-14
DE60309565D1 (de) 2006-12-21
US8105627B2 (en) 2012-01-31
DE60309565T2 (de) 2007-03-15
HK1070821A1 (en) 2005-06-30
PT1473030E (pt) 2007-01-31
AU2003285739A1 (en) 2004-11-23
ES2277030T3 (es) 2007-07-01
CA2524241A1 (en) 2004-11-11
WO2004096186A1 (en) 2004-11-11
EP1473030A1 (de) 2004-11-03
DE60309565T3 (de) 2015-01-15
EP1473030B1 (de) 2006-11-08

Similar Documents

Publication Publication Date Title
AU686168B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
ATE344659T1 (de) Tablettenzubereitung mit verlängerter freisetzung von venlafaxin
JO2555B1 (en) Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
WO2007103557A3 (en) Coating capsules with active pharmaceutical ingredients
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
DE17169621T1 (de) Pharmazeutische zubereitung mit oxycodon und naloxon
MX2007000008A (es) Formas farmaceuticas orales, protegidas frente al abuso, que contienen (1r,2r)-3-(3-dimetilamino-1-etil-2-metil-propil) fenol.
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
YU31599A (sh) Brzo oslobadjajući i za ukus maskirajući farmaceutski oblik doze
DE69528838T2 (de) Verbesserte,ibuprofen und codein enthaltende,pharmazeutische zusammensetzungen
IL161628A0 (en) Pharmaceutical dosage form with multiple coatings
HRP20070353T3 (en) Extended release coated minitablets of venlafaxine hydrochloride
BR0014965A (pt) Composição de revestimento de pronta liberação, endurecìvel e comestìvel, forma de dosagem sólida, e, método para formar uma composição de revestimento de pronta liberação, endurecìvel e comestìvel
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
BR0211198A (pt) Composições farmacêuticas e seu uso
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
BRPI0412354A (pt) formulação com liberação prolongada para cloridrato de venlafaxina
MXPA05004412A (es) Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas.
WO2006081779A3 (en) A pharmaceutical composition containing olanzapine as the active agent and a process for the preparation thereof
JP2005538117A5 (de)
CN101822649B (zh) 一种带花彩的片剂的制备方法
BR0115206A (pt) Composições hidroliticamente instáveis
EP3329910A1 (de) Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von nagelmykose und herstellungsverfahren dafür
EP1107740A1 (de) Naproxen und pseudoephedrin enthaltendetablette mit zeitgesteuerter freisetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1473030

Country of ref document: EP